Article
Myricetin suppressed DSS-induced colitis and promoted the therapeutic success of Infliximab in TNBS-induced colitis
2024-06-06
Abstract excerpt
<title>Abstract</title> <p>Infliximab (IFX) is widely used in the treatment of inflammatory bowel diseases (IBD) such as ulcerative colitis (UC) and Crohn's disease (CD). Still, long-term use may be ineffective or suggest some side effects. This study investigated the role of Myricetin, a flavonoid, alone and its complementary therapeutic potential in combination with IFX against UC, CH, and cancerization. DSS tr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 54bdbeff-a88b-59d6-a833-75d77b563df2
- DOI
- 10.21203/rs.3.rs-4447222/v1
